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Silyl glyoxylates, which can be viewed as a derivative of an a-hydroxy acid known as 
glyoxylic acid, have been explored as linchpin reagents for nucleophile and electrophile coupling 
in recent years. Based on prior works justifying the use of rhodium-(I) as a catalyst for performing 
1,2-additions to carbonyls and imines, a novel rhodium catalyzed coupling reaction was proposed. 
Using a silyl glyoxylate as a linchpin reagent, new stereocomplex glycolates were synthesized 
from a variety of arylboronic acids and benzaldehyde. In order to further evaluate the efficacy of 
the reaction, medicinally relevant amine species were considered. Syntheses of (4-(1-methoxy-
1,3-dioxo-3-(piperidin-2-yl) propan-2-yl) phenyl) boronic acid and (4-(2-((tert-butoxycarbonyl) 
amino) ethyl) phenyl) boronic acid were undertaken with the ultimate goal of utilizing them in the 
three-component reaction. Finally, a related two component coupling reaction was developed, 
utilizing a proton as an electrophile source rather than an aldehyde.  
 
INTRODUCTION  
 The a-hydroxy acid/ester motif is present in a wide variety of natural products, leading to 
expansive applications in numerous industries, ranging from skincare to pharmaceutical. The 
simplest a-hydroxy acids include glycolic acid, lactic acid, and mandelic acid, but other common 
a-hydroxy acids include citric acid, malic acid, and glyoxylic acid.  
 
Figure 1. Common a-hydroxy acids.  
Serums of glycolic acid and lactic acid have been popularized in the skincare industry based on 
numerous dermatological studies showing its efficacy in treating acne and signs of aging.1,2 While 
the mechanism is not known to this point, it has been suggested that these a-hydroxy acids are 






























and dry cells to flake off, leading to brighter appearing skin and promoting new skin growth.2 
Additionally, the presence of mandelic acid in urine can be utilized to detect exposure to styrene. 
This is essential to monitoring working conditions in facilities that create plastics, as though 
styrene is not a known carcinogen, it can lead to adverse health effect ranging from drowsiness 
and eye irritation to liver damage and negative effects on reproductive organs.3 
Recently, a simple one-pot method was developed to convert mandelic acid into phenyl 
glyoxylic acid, which is an essential motif in anti-hypertensive agents and thromboxane synthetase 
inhibitors, which are used to reduce platelet synthesis and vasoconstriction. 4–6  
 
Scheme 1. One-pot method to convert racemic mandelic acid into phenyl glyoxylic acid pioneered 
by Tang et al. 
The use of 2-silyl-2-oxoacetates, also referred to as “silyl glyoxylates” has become 
increasingly common in recent years.7–9 Silyl glyoxylates can be viewed as 
a derivative of glyoxylic acid, and is a useful for producing a variety of 
stereocomplex glycolates. Bolm was the first to perform reactions with silyl 
glyoxylates. By treating a benzyl silyl glyoxylate with H2 and Pd/C, in 
addition to hydrogenolyzing the benzyl ester, the silyl ketone was able to be hydrogenated to afford 
the a-silyl-a-hydroxy acid. By treating the same starting material with NaBH4, the silyl ketone 
was hydrogenated to afford the a-silyl-a-hydroxy benzylic ester.10  
 





























Silyl glyoxylate reagents are unique in their ability to act as a variety synthons; they can 
serve as a dipolar glycolate synthon, a glyoxylate anion synthon, or an a-keto ester homoenolate 
synthon, all of which combined allows them to function as both a nucleophile and an electrophile.7  
 
Figure 2. A generic silyl glyoxylate and its applications as various synthons. 
The Johnson Group began exploring the coupling of these silyl glyoxylates with other 
reagents in hopes of exploiting the dipolar glycolate reactivity. The acylsilane unit is highly 
susceptible to nucleophilic attack. At this point, the generated alkoxide easily undergoes a C à O 
silyl group transfer, known as a Brook rearrangement, to reveal a resonance stabilized anion. The 
resulting enolate is able to trap an electrophilic species to generate a conjunctive coupling product, 
uniting two different reactive units via the silyl glyoxylate “staple.”11 
 
Scheme 3. Use of silyl glyoxylates as linchpin reagents to couple a nucleophile and electrophile 
by utilizing its dipolar reactivity. 
In an effort to prove this proposed reactivity, they began attempting numerous reactions. 
Initially, they discovered that organometals with b-hydrogens, when in the presence of Lewis 
acids, did not undergo the desired alkylation, rather they underwent further reduction. In an effort 
to avoid the undesired reduction pathway, they considered nucleophiles that lacked beta-
hydrogens. By utilizing metal acetylides generated from terminal alkynes with Zn-(II) and Et3N as 
nucleophiles, combined with a silyl glyoxylate and an aldehyde, the desired reaction pathway was 
achieved. Following this, a similar three-component coupling reaction was done using a Grignard 












































Figure 3.  Reaction schemes for two successful examples of the three-component coupling of an 
alkene/alkyne with an aldehyde using a silyl glyoxylate as a linchpin reagent.  
The strategy of using silyl glyoxylates to generate stereocomplex glycolates has been used 
by the Johnson group to synthesize multiple natural products. One such natural product, zaragozic 
acid C, is a complex fungal metabolite that is essential to the 
production of squalene synthetase inhibitors. Squalene is a 
precursor to numerous human steroids such as cholesterol and is 
synthesized in the liver, and numerous cholesterol-lowering drugs 
feature a zaragozic acid motif.12  Silyl glyoxylates served as a key 
synthon for this synthesis due to the high frequency of glycolic 
acid substituents in the molecule. In the following first step of the synthesis, by utilizing a silyl 
glyoxylate with a Grignard reagent, three stereocenters were set, all of which benefitted from the 
use of this synthon.13  
 
Scheme 4. Key synthetic step in the Johnson total synthesis of zaragozic acid C involving silyl 

















a. Three component coupling initiated by additon of an acetylide.
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Based on the previous successes with silyl glyoxylates, the Johnson group began exploring 
another three-component coupling reaction, ideally featuring a transition metal catalyst rather than 
an organometallic starting material. Previous work by the Hayashi group has shown the ability of 
rhodium-(I) to catalyze the addition of an organoboronic acid to an enone.  
 
 
Figure 4. Top: general reaction scheme of rhodium-(I) catalyzed addition of an organoboronic 
acid to an enone. Bottom Left: Various enones utilized in the reaction. Bottom Right: various 
arylboronic acids utilized in the reaction. 
This work was especially noteworthy, as though 1,4-conjugate additions were known to 
this point, this allowed the use of air and water-stable starting materials, and it eliminated the 
competing 1,2-conjugate addition side-product seen in other methods. Since then, rhodium-(I) has 
not only been shown to allow arylboronic acids to numerous other Michael acceptors, but also 
been shown to allow for 1,2-additions to carbonyls and imines.14 Given this precedent, a rhodium-
(I) catalyst with an arylboronic acid seemed to provide an interesting opportunity to explore the 
dipolar glycolate reactivity of arylboronic acids. This work expands on these transformations, 
including a previously unreported three-component coupling reaction of a silyl glyoxylate, an 
aromatic boronic acid, and an aldehyde, in addition to the related two-component coupling of a 























The synthetic procedures in this section are outlined in greater detail in Supplemental 
Information. Presence and purity of desired products was determined using 1H NMR in all cases, 
and relevant spectra are also included in Supplemental Information. 
 
Part I. Rhodium catalyzed three-component coupling of a silyl glyoxylate, benzaldehyde, and an 
arylboronic acid.  
The scope of the three-component coupling of silyl glyoxylates, arylboronic acids, and 
benzaldehyde was accomplished using methods developed by former Johnson Group member Dr. 
Kendrick Smith and current member Jacob Robins.11  
 
Scheme 5. Reaction scheme for the three-component coupling of a silyl glyoxylate, a generic 
arylboronic acid, and benzaldehyde. 
The racemic products are isolable by column chromatography; however, efforts have not been 
made up to this point to separate the diastereomers. The generalized conditions developed by the 
aforementioned Johnson group members worked well in most cases with one exception. It was 
difficult to obtain consistent results across trials due to challenges associated with weighing small 
quantities of catalyst in the glove box. As a result, I created and used a stock solution of the 
rhodium catalyst to improve reproducibility and reduce the amount of wasted rhodium arising from 
the weighing process.   
 
Part II: Synthesis of new boronic acids for evaluation of their performance in the rhodium 
catalyzed three-component coupling of a silyl glyoxylate, benzaldehyde, and an arylboronic acid. 
 In order to further evaluating the scope of the three-component coupling reaction from Part 
I, we decided to explore the use of more exotic arylboronic acid coupling partners in this reaction.  
After analyzing numerous common pharmaceuticals, I was especially inspired by the common 




[Rh(cod) Cl]2 (2.5 mol%),
K2CO3 (6 equiv.), 













methylphenidate-4-boronic acid with hopes of utilizing it as a coupling partner in the three-
component coupling reaction to produce a stereocomplex and pharmaceutically relevant product.   
 
Scheme 6. General transformation of methylphenidate into methylphenidate-4-boronic acid, 
followed by the proposed product of this arylboronic acid when reacted with a silyl glyoxylate and 
benzaldehyde according to Scheme 5. 
In order to accomplish this, the following synthetic scheme was proposed using methods found in 
the literature.15,16  
 
Scheme 7. Synthetic scheme of a methylphenidate-inspired boronic acid. 
While the synthetic procedure proposed in Scheme 7 was ultimately unsuccessful, I remained 
inspired by amines, notably the carbamic acid/ester motif found in numerous other 
pharmaceuticals. I proposed a synthesis of (4-(2-((tert-butoxycarbonyl) amino) ethyl) phenyl) 
boronic acid in hopes that it could be coupled with benzaldehyde and a silyl glyoxylate in the 
reaction shown in Part I.17–21 
 





























a. CH insertion 
b. Lactam 
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DMF: H2O (9.5:1.0)2. PBr3; DCM, 0 ºC
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Part III. Rhodium catalyzed two-component coupling of a silyl glyoxylate and an arylboronic acid. 
 A two-component coupling of a silyl glyoxylate and an arylboronic acid was observed as 
a side reaction of the three-component coupling reaction shown in Part I. In order to expand upon 
the scope of this reaction, a similar method was utilized.  
 
Scheme 9. Reaction scheme for the two-component coupling of tertbutyl silyl glyoxylate and a 
generic arylboronic acid. 
The racemic products were purified via flash chromatography.  
 
RESULTS AND DISCUSSION 
Part I. Rhodium catalyzed three-component coupling of a silyl glyoxylate, benzaldehyde, and an 
arylboronic acid. 
By using a rhodium-(I) catalyst, the coupling of benzaldehyde and an arylboronic acid 
using silyl glyoxylate as a linchpin reagent was shown to produce glycolate 3.  
 
Scheme 10. Reaction scheme for the three-component coupling of a silyl glyoxylate, a generic 
arylboronic acid, and benzaldehyde. 
Based upon the literature of rhodium-catalyzed couplings of arylboronic acids with 
carbonyls and previous work in the Johnson group developing catalytic methods using silyl 
glyoxylates, the proposed mechanistic pathway for the three-component coupling reaching is 















[Rh(cod) Cl]2 (2.5 mol%),
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Scheme 11. Proposed mechanism of the three-component coupling reaction. 
Initially, the rhodium catalyst undergoes transmetalation of the aromatic group on the boronic acid 
onto the metal (I). The silyl glyoxylate then undergoes a 1,2-arylation to produce an a-silyl tertiary 
rhodium-alkoxide (II). At this point, a Brook rearrangement occurs, producing enolate III. The 
enolate is then trapped with benzaldehyde via a Rh-(I) aldol addition to produce the benzylic 
rhodium alkoxide IV, which then undergoes transmetalation to release the desired product 3. 
In order to expand upon the scope of the three-component coupling reaction shown in 
Scheme 6, a variety of boronic acids were purchased to better understand the breadth of the 











































Figure 5. Glycolates 3a-3c were obtained in moderate yields 
Figure 6. Attempts to synthesize glycolates 3d-3g were unsuccessful. 
Based on 1H NMR spectra obtained of both the crude and purified products, it is clear that the 
racemic reaction proceeds with relatively high diastereomeric preference, however, as previously 
mentioned, attempts have not been made to separate the diastereomers. While 3a-3c were 
synthesized and quantified by NMR, purification of the product was difficult in many cases, 
usually stemming from product desilylation. Glycolates 3d-3g were not successfully produced, 
likely for a variety of reasons. The electron withdrawing nature of pyrimidine-5-boronic acid likely 
reduced its reactivity because the two nitrogen atoms inductively draw electron density away from 
the nucleophilic carbon, thus hindering the progress of the overall reaction. The trisubstituted 
boronic acid forming 3e likely was too sterically bulky to allow for product formation, in addition 
to the moderately withdrawing nature of the two ortho-substituted fluorine atoms. To this point, it 
is unclear why products 3f and 3g are not produced. They are derived from electron rich boronic 
































































Part II: Synthesis of new boronic acids for evaluation of their performance in the rhodium 
catalyzed three-component coupling of a silyl glyoxylate, benzaldehyde, and an arylboronic acid. 
Though the previously attempted heterocyclic substrates had proven unsuccessful, because 
of the prevalence of nitrogen heterocycles in pharmaceuticals, I shifted my 
approach towards synthesizing a potentially medicinally significant boronic acid. 
Inspired by the common ADHD medication methylphenidate, more commonly 
known as Ritalin, the synthetic procedure shown below in Scheme 12 was 
developed. The feedstock material 4-bromo(phenyl) acetic acid (4) was first trans esterified then 
aminated to produce 2-(4-bromophenyl)-1-(piperidin-1-yl) ethan-1-one (5). Utilizing pABSA and 
DBU, a diazo transfer to 2-(4-bromophenyl)-1-(piperidin-1-yl) ethan-1-one (5) was then 
attempted.   
 
Scheme 12. Synthetic scheme outlining the attempted synthesis of a methylphenidate-inspired 
boronic acid, (4-(1-methoxy-1,3-dioxo-3-(piperidin-2-yl) propan-2-yl) phenyl) boronic acid. 
While the first two steps proceeded with full conversion, the diazo transfer was unsuccessful. 
Despite the lack of success with the diazo transfer, I remained inspired by amine-containing 
pharmaceutical compounds. Furthermore, a phenethylamine motif is extraordinarily common in 
psychoactive pharmaceutical compounds. A synthesis of a BOC protected 4-phenethylamine 
boronic acid for use in the three-component coupling reaction was then proposed (Scheme 13). 
Starting with 4-bromobenzaldehyde (8), this feedstock was reduced to the alcohol then brominated 
with PBr3 to produce 2-bromo-4-(bromomethyl) benzene (9). This product was then treated with 
NaCN to produce 2-4-(bromophenyl) acetonitrile (10), which was then reduced with borane THF 
to produce amine 11. 2-4-(bromophenyl) ethan-1-amine (11) was then Boc-protected to produce 
12. Finally, efforts were made to borylate 12 using bis(pinacolato)diboron and catalytic 1,1’-















a. CH insertion 
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Scheme 13.  Proposed synthesis of protected amine-based phenyl boronic acid. 
The reduction and bromination steps proceeded with full conversion, and the cyanation 
proceeded in 66% yield. The first major challenge arose, however, with the following reduction. 
Initially, two equivalents of LiAlH4 were used as the reducing agent, but the yield was 
extraordinarily poor. However, when two equivalents of borane·THF were used, the reaction 
proceeded with full conversion. Next, product 11 was protected with BOC and TEA, which 
proceeded with 37% yield. In order to improve yields, three different protecting conditions were 
screened: BOC and TEA in DCM, BOC and TEA in IPA, and BOC in THF without TEA. 
Unfortunately, this project was placed on indefinite hold due to the abrupt shutdown of research 
on campus due to COVID-19. At the same time, product 12 was purified and used in the borylation 
step. While this step did yield some product, it was not purified due to COVID-19.  
 
Part III. Rhodium catalyzed two-component coupling of a silyl glyoxylate and an arylboronic acid. 
 Upon returning to campus, my focus shifted towards further developing a side reaction of 
the three-component coupling reaction. This two-component coupling reaction utilized the same 
rhodium catalyst to couple a similar silyl glyoxylate starting material and a variety of aromatic 
boronic acids via a Brook rearrangement.  
 
Scheme 14. Reaction scheme for the two-component coupling of tertbutyl silyl glyoxylate and a 
























































Based on the previously determined mechanism for the three-component coupling reaction 
(Scheme 11) and the observed side reaction (Scheme 14), Dr. Kendrick Smith and co-workers 
proposed the following mechanistic scheme for this reaction.11 
 
Scheme 15. Proposed mechanism of two component coupling of a silyl glyoxylate and an 
arylboronic acid.  
Initially, the rhodium catalyst is activated by the transmetalation of the aromatic group on the 
boronic acid onto the metal (I). The silyl glyoxylate then undergoes a 1,2-arylation to produce an 
a-silyl tertiary rhodium-alkoxide (II). At this point, a Brook rearrangement occurs, producing 
enolate III. The enolate then immediately undergoes transmetallation to release the desired product 
(16). In order to expand upon the scope of the two-component coupling reaction shown in Scheme 
14, a variety of boronic acids were purchased to better understand the breadth of the reaction. The 
























Figure 7: Glycolates 16a-16e were synthesized in high yields.  
 
Figure 8. Glycolates 16f and 16g were synthesized based on crude NMR, but were unable to be 
isolated.  
 



























16a (72%)a 16b* 83%b (27.2%)b 16c 84%a (80.7%)b
16d 86%a (69%)a 16e 84%a (53%)a
Key: Yield reported as NMR (isolated)              *Reaction run in 1,4-dioxane rather than PhMe
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Similar to the three-component reaction, this reaction requires electron rich boronic acids 
to proceed in measurable yields. Because of the electron rich nature of the corresponding boronic 
acids, products 16a-16e were synthesized in high yields. Glycolates 16h-16m were not synthesized 
because the aromatic group on the boronic acid was not electron rich enough.  Additionally, 
products 16n and 16o were not synthesized because the reaction does not appear to proceed with 
aryl vinylboronic acids. Interestingly, products 16f and 16g were synthesized as evidenced by 
crude 1H NMR spectra, however, despite multiple attempts, they could not be isolated due to 
decomposition during flash chromatography.  
 
CONCLUSION 
 We have developed a novel rhodium catalyzed coupling reaction between a variety of 
arylboronic acids and an aldehyde, using a silyl glyoxylate as a linchpin reagent. These reactions 
occurred with moderate success, and allowed for greater understanding of the breadth of the 
reaction. Inspired by medicinally relevant amine motifs, we proposed syntheses of (4-(1-methoxy-
1,3-dioxo-3-(piperidin-2-yl) propan-2-yl) phenyl) boronic acid and (4-(2-((tert-butoxycarbonyl) 
amino) ethyl) phenyl) boronic acid with the ultimate goal of utilizing them in the three-component 
reaction. However, due to a variety of circumstances, these syntheses were largely unsuccessful. 
Finally, by exploring the variety of boronic acids able to be coupled with silyl glyoxylate 14, I was 
able to discern patterns in what reactions were successful and which were not. In all, this work 
provides a window into possible reactions with silyl glyoxylate starting materials and arylboronic 
acids that can be used to generate stereochemically complex products.  
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General Methods: All reactions were carried out open to air unless otherwise noted. Thin layer 
chromatography (TLC) was performed on Sorbent Technologies 0.20 mm Silica Gel TLC plates. 
Visualization was accomplished using UV light and Magic Stain. Flash chromatography was 
performed under pressurized air using Siliaflash-P60 silica gel (40-63 µm) purchased from 
Silicycle.  
Instrumentation and Data Acquisition: Proton (1H) and carbon (13C) nuclear magnetic resonance 
spectra were obtained on Bruker Avance 400 MHz, Bruker NEO Avance 400 MHz, Bruker Avance 
III 500 MHz, Bruker NEO Avance 600 MHz, or a Bruker Avance III 600 instruments, using 
solvent resonances for internal chemical shift calibration (1H NMR: CDCl3 at δ=7.26 ppm; 13C 
NMR: CDCl3 at δ=77.0 ppm).  
Data Reporting: The following format is used for the presentation of 1H NMR spectroscopic data: 
magnet strength, analysis solvent, chemical shift (ppm), multiplicity (s = singlet, br s = broad 
singlet, app s = apparent singlet, d = doublet, bd = broad doublet, t = triplet, app t = apparent triplet, 
q = quartet, app q = apparent quartet, dd = doublet of doublets, td = triplet of doublets, app td = 
apparent triplet of doublets, ddd = doublet of doublet of doublets, ddt =doublet of doublet of 
triplets, app ddt = apparent doublet of doublet of triplets, dddd = doublet of doublet of doublet of 
doublets, m = multiplet), J-coupling constants (Hz), and integration.  
 
Materials: Unless otherwise stated, technical grade solvents were used as received. Anhydrous 
tetrahydrofuran (THF), diethyl ether (Et2O), methylene chloride (DCM, CH2Cl2), toluene (PhMe), 
and triethylamine (TEA, NEt3) were obtained by passage of the respective solvents through a 
neutral alumina column under nitrogen. Solvent ratios are reported as volume ratios.  
 
Detailed Synthetic Procedures  
General Procedure A: Three-component coupling of silyl glyoxylate (1) with benzaldehyde 
and arylboronic acid to produce products 3a-3c 
Silyl glyoxylate 1 (0.1 mmol) and benzaldehyde (2 equiv.) were weighed in a 1-dram vial and 
purged with argon. Proton sponge (1 equiv.) was weighed in a separate 1-dram vial and purged 
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with argon. In the glovebox, potassium carbonate (6 equiv.) and arylboronic acid (2 equiv.) were 
weighed into a third flame dried vial with a stir flea. The silyl glyoxylate, benzaldehyde, and proton 
sponge were transferred into the third vial using 0.9mL of anhydrous toluene divided into three 
0.3 mL transfers. Then, 0.1 mL of [Rh(cod)Cl]2 solution in toluene (0.0026 mmol dimer/0.1 mL 
solution) was added to the reaction vial, which was sealed with a screw cap. The reaction vial was 
brought out of the glovebox and stirred vigorously at room temperature for 48 h. The reaction was 
then filtered through a silica plug with 30% EtOAc/Hexanes and a couple drops of water to aid in 
filtration. The filtrate was concentrated in vacuo and the crude residue was purified by flash 




((trimethylsilyl)oxy) propanoate (3a): Reaction was performed according to 
General Procedure A on a 0.1 mmol scale of 1, using 4-biphenylboronic acid. 




phenyl-2-((trimethylsilyl)oxy) propanoate (3b): Reaction was performed 
according to General Procedure A on a 0.1 mmol scale of 1, using (5-
chloro-2-fluorophenyl) boronic acid. The product glycolate 3b  was unable 
to be isolated. 
 
2,6-diisopropylphenyl 3-hydroxy-3-phenyl-2-(4-(trifluoromethyl) 
phenyl)-2-((trimethylsilyl) oxy) propanoate (3c): Reaction was performed 
according to General Procedure A on a 0.1 mmol scale of 1, using (4-
(trifluoromethyl)phenyl)boronic acid. The product glycolate 3c  was unable 
to be isolated 
______________________________________________________________________________ 
Synthetic procedures utilized to produce a methylphenidate-inspired boronic acid: These 
























 2-(4-bromophenyl)-1-(piperidin-1-yl)ethan-1-one (5): 1) 2-(4-
bromophenyl) acetic acid (46.50 mmol) was dissolved in methanol (1 
equiv.). H2SO4 (1 equiv.) was added, and the solution was heated under 
reflux for 16 h. The reaction was concentrated then diluted with ethyl 
acetate. It was then washed with saturated sodium bicarbonate and brine. The organic layer was 
then dried over sodium sulfate, filtered, and concentrated.15 2)  The product was then stirred with 
ammonium nitrate (0.5 equiv.) and piperidine (3 equiv.) for 48 h. The reaction as then stirred with 
50 mL of 1M HCl. The solid product was then filtered and dissolved in ethyl acetate. The solution 
was washed with brine, then dried over sodium sulfate, filtered, and the solvent was evaporated.16 
The product was then immediately used for the next transformation. 
 
 2-(4-bromophenyl)-2-diazo-1-(piperidin-1-yl) ethan-1-one (6): 2-(4-
bromophenyl)-1-(piperidin-1-yl)ethan-1-one (5) and pABSA (1.1 equiv.) were taken up in 
acetonitrile (340 mL) under nitrogen and cooled to 0 oC. DBU (2,3,4,6,7,8,9,10-
octahydropyramido[1,2-a] azepine (1.1 equiv.) was then added dropwise to the flask, causing an 
instant color change to orange then to deep red with prolonged stirring. 
The reaction was then stirred at room temperature under nitrogen for 30 h. The reaction was 
directly concentrated in vacuo, then dissolved again in DCM with silica and filtered over a pad of 
clean silica with 1:1 Et2O/Hexanes. No product was observed.  
______________________________________________________________________________ 
Synthetic procedures utilized to produce (4-(2-((tert-butoxycarbonyl) amino) ethyl) phenyl) 
boronic acid: These procedures were all adapted from known literature procedures.17–21 
 
 1-bromo-4-(bromomethyl) benzene (9): 1) Methanol (100 mL) was added to 
a flask containing bromobenzaldehyde (27 mmol) and stirred. NaBH4 (1.17 
equiv.) was added slowly at 0 oC under nitrogen and allowed to stir for 40 h. 
Water was added and the product was then concentrated in vacuo. The aqueous layer was extracted 














dissolved in DCM (58.0 mL), and PBr3 (0.4 equiv.) was then added, and the reaction was stirred 
for one hour at room temperature. The product was then concentrated in vacuo and no further 
purification was required.17 The product was then immediately used for the next transformation. 
 
2-(4-bromophenyl)acetonitrile (10): 1-bromo-4-(bromomethyl) benzene (9) 
and NaCN (1.2 equiv.) were suspended 10:1 DMF : water and stirred at 40 oC 
for 72 h. The reaction mixture was then quenched with water and extracted 
with EtOAc. It then was washed with brine, dried over sodium sulfate, and concentrated in vacuo.18 
The product was then immediately used for the next transformation. 
 
2-(4-bromophenyl)ethan-1-amine (11): Borane tetrahydrofuran complex 
(2 equiv.) was added to 2-(4-bromophenyl)acetonitrile (10) in THF (3.1 
mL) dropwise at 0oC under nitrogen. The reaction was covered for 30 
minutes then allowed to reflux for 24 h. The reaction mixture was then quenched with methanol 
(12 equiv.) and HCl (3.0 equiv.; half the volume of THF added), then heated to reflux for another 
4 h. The mixture was then concentrated in vacuo, diluted with water and extracted with EtOAc. 
The aqueous layer was neutralized with NaOH (15%) and extracted again with EtOAc. The organic 
layer was dried with brine and sodium sulfate, then concentrated again in vacuo.19 The product 
was an orange oil that was not weighed and immediately used for the next transformation. 
 
tert-butyl (4-bromophenethyl) carbamate (12): 2-(4-
bromophenyl) ethan-1-amine (11) was dissolved in DCM. TEA (2.1 
equiv.) was then added, followed by di-tert-butyl dicarbonate (1.05 
equiv.) in DCM. The reaction was allowed to stir at room 
temperature for 30 minutes, then washed with water. It was then dried with sodium sulfate and 
concentrated in vacuo. The crude product was purified by flash chromatography on silica with 
















(4-(2-((tert-butoxycarbonyl) amino) ethyl) phenyl) boronic 
acid (13): In the glovebox, tert-butyl (4-bromophenethyl) 
carbamate (12) was dissolved in toluene (1.43 mL) and 1,1’-
bis(diphenylphosphino)ferrocene-palladium (II) dichloride 
dichloromethane complex (0.1 equiv.) was added. Potassium acetate (3 equiv.) and 
bis(pinacolato)boron (1.5 equiv.) was then added. The reaction mixture was stirred at 90 oC for 45 
h. The reaction was then washed with water and extracted thrice with EtOAc. The organic layer 
was then washed with water and brine, then dried with sodium sulfate and concentrated in vacuo.21 
The crude product was never purified.  
 
General Procedure B: Two- component coupling of a silyl glyoxylate (14) with arylboronic 
acids to produce products 16a-16e. 
Silyl glyoxylate 14 (0.2 mmol) was weighed in a 1-dram vial and purged with argon. In the 
glovebox, potassium carbonate (3 equiv.) and arylboronic acid (2 equiv.) were weighed into a third 
flame dried vial with a shaved-end stir bar. The silyl glyoxylate, benzaldehyde, and proton sponge 
were transferred into the third vial using 0.53 mL of anhydrous toluene*1 divided into three 0.17 
mL transfers. Then, 0.1 mL of [Rh(cod)Cl]2 solution in toluene (0.0026 mmol dimer/0.1 mL 
solution) was added to the reaction vial, which was sealed with a screw cap. The reaction vial was 
brought out of the glovebox and 0.07 mL of water was added. The seal was then reconstituted with 
parafilm and the reaction was stirred vigorously at room temperature for some time (length 
depended on reaction). The reaction was then filtered through a silica plug with 30% 
EtOAc/Hexanes and the filtrate was concentrated in vacuo. The crude residue was purified by flash 
chromatography on silica using ethyl acetate and hexanes (ratio depended on the reaction).11 
______________________________________________________________________________ 
tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(4-chlorophenyl)acetate 
(16a): Reaction was performed according to General Procedure B on a 0.2 
mmol scale of 14, using 4-chlorophenylboronic acid. The crude mixture was 
purified using 100% Hexanes à 2.5%-5% EtOAc/Hexanes. The product 
glycolate 16a  was obtained as a clear oil (50.6 mg, 72% yield). 
 
                                               















(16b): Reaction was performed according to General Procedure B on a 0.2 
mmol scale of 14, using 4-hydroxyphenylboronic acid. The reaction was run 
in 0.53 mL of anhydrous 1,4-dioxane (rather than toluene). The crude mixture was purified using 
100% Hexanes à 2.5%-10% EtOAc/Hexanes. The product glycolate 16b  was obtained as a clear 
oil (18.5 mg, 27% yield). 
 
tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(4-methoxyphenyl)acetate 
(16c): Reaction was performed according to General Procedure B on a 
0.2 mmol scale of 14, using 4-methoxyphenylboronic acid. The crude 
mixture was purified using 100% Hexanes à 2.5%-5% EtOAc/Hexanes. 
The product glycolate 16c  was obtained as a clear oil (56.9 mg, 81% yield). 
 
tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(1-methyl-1H-indol-5-
yl)acetate (16d): Reaction was performed according to General Procedure 
B on a 0.2 mmol scale of 14, using (1-methyl-1H-indol-5-yl)boronic acid. 
The crude mixture was purified using 100% Hexanes à 2.5%-5% 
EtOAc/Hexanes. The product glycolate 16d  was obtained as a white crystal, (58.1 mg, 77% yield). 
 
tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(6-methoxypyridin-3-
yl)acetate (16e): Reaction was performed according to General 
Procedure B on a 0.2 mmol scale of 14, using (6-methoxypyridin-3-
yl)boronic acid. The crude mixture was purified using 100% Hexanes à 




(16f): Reaction was performed according to General Procedure B on a 0.2 
mmol scale of 14, using 4-nitrophenylboronic acid. The reaction was run in 
0.53 mL of anhydrous 1,4-dioxane (rather than toluene). The product 


































tert-butyl 2-((tert-butyldimethylsilyl) oxy)-2-(3,-5-(trifluoromethyl) 
phenyl) acetate (16g): Reaction was performed according to General 
Procedure B on a 0.2 mmol scale of 14, using (3,5-
trifluoromethyl)phenylboronic acid. The product glycolate 16g  was unable 











Figure S1: 1H NMR of tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(4-chlorophenyl)acetate 
(16a).  
1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 8.6 Hz, 1H), 7.30 (d, J = 8.5 Hz, 1H), 5.05 (s, 1H), 
1.39 (s, 9H), 0.91 (s, 9H), 0.12 (s, 3H), 0.03 (s, 3H).  
13C NMR (126 MHz, CDCl3) δ 170.88, 138.24, 133.57, 128.35, 127.63, 81.58, 77.29, 77.04, 
76.78, 74.15, 27.87, 25.71, 18.33, -4.93, -5.23. 







Figure S2: 1H NMR of tert-butyl 2-((tert-butyldimethylsilyl) oxy)-2-(4-hydroxyphenyl)acetate 
(16b).  
1H NMR (600 MHz, Chloroform-d) δ 7.32 (d, J = 8.4 Hz, 1H), 6.78 (d, J = 8.5 Hz, 1H) 5.02 (s, 
1H), 4.86 (s, 1H), 1.39 (s, 9H), 0.91 (s, 9H), 0.11 (s, 3H), 0.02 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 171.62, 155.19, 132.10, 127.74, 115.03, 81.23, 77.24, 77.03, 
76.81, 74.32, 27.90, 25.76, 18.34, -4.92, -5.15. 





Figure S3: 1H NMR of tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(4-methoxyphenyl)acetate 
(16c).  
1H NMR (400 MHz, Chloroform-d) δ 7.37 (d, J = 8.5 Hz, 1H), 6.86 (d, J = 8.8 Hz, 1H), 5.03 (s, 
1H), 3.80 (s, 1H), 1.39 (s, 9H), 0.91 (s, 9H), 0.11 (s, 3H), 0.02 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 171.66, 159.32, 132.08, 127.65, 113.66, 81.25, 77.37, 77.16, 
76.95, 74.46, 55.49, 55.34, 28.04, 25.89, 18.48, -4.78, -5.01. 
TLC: Rf=0.33 in 5% EtOAc/Hex; UV active; dark blue with heated Magic Stain. 
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Figure S4: 1H NMR of tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(6-methoxypyridin-3-
yl)acetate (16d). 
1H NMR (400 MHz, Chloroform-d) δ 8.20 (d, J = 2.4 Hz, 1H), 7.69 (dd, J = 8.6, 2.4 Hz, 1H), 6.72 
(d, J = 8.6 Hz, 1H), 5.04 (s, 1H), 3.93 (s, 1H), 1.40 (s, 9H), 0.91 (s, 9H), 0.12 (s, 3H), 0.03 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 170.92, 163.96, 144.95, 136.93, 128.31, 110.63, 81.65, 77.24, 
77.03, 76.81, 72.47, 53.47, 27.90, 25.70, 18.30, -4.92, -5.21. 





Figure S5: 1H NMR of tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(1-methyl-1H-indol-5-
yl)acetate (16e).  
1H NMR (600 MHz, Chloroform-d) δ 7.34 (d, J = 8.5 Hz, 1H), 7.26 (d, J = 11.3 Hz, 2H), 7.03 (d, 
J = 3.0 Hz, 2H), 6.47 (d, J = 3.0 Hz, 2H) 5.18 (s, 1H), 3.78 (s, 1H), 1.38 (s, 9H), 0.93 (s, 9H), 0.12 
(s, 3H), 0.02 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 172.02, 136.46, 130.86, 129.00, 128.15, 120.37, 119.04, 108.88, 
101.17, 80.83, 77.25, 77.03, 76.82, 75.35, 32.89, 27.95, 25.83, 18.40, -4.89, -5.04. 
TLC: Rf=0.25 in 5% EtOAc/Hex; UV active; pink upon contact with Magic Stain, dark blue with 




Figure S6. 1H NMR of tert-butyl 2-(tert-butyldimethylsilyl)-2-oxoacetate (14).  
1H NMR (400 MHz, Chloroform-d) δ 1.55 (s, 9H), 0.96 (s, 9H), 0.26 (s, 3H). 
Rf=0.40 in 5% EtOAc/Hex; UV active; light blue with heated Magic Stain 
Rf=0.24 in 10% EtOAc/Hex; UV active; light blue with heated Magic Stain 
